[ Price : $8.95]
BridgeBio Pharma says it will file by 12/31 an NDA for acoramidis after releasing Phase 3 data from its ATTRibute-CM study of acor...[ Price : $8.95]
Novo Nordisk says data from its landmark Phase 3 SELECT cardiovascular outcomes trial assessing the effects of once-weekly Wegovy ...[ Price : $8.95]
FDA clears an InMed.AI 510(k) for NeuroShield, which the company describes as an automated brain geometry-based quantifying analyt...[ Price : $8.95]
FDA approves a Pacira BioSciences supplemental NDA to expand Exparels (bupivacaine liposome injectable suspension) label to includ...[ Price : $8.95]
FDA gives Brixton Biosciences a breakthrough device designation for its Coolio Therapy, which is intended to deliver long-lasting ...[ Price : $8.95]
Covidien recalls its McGrath MAC Video Laryngoscope in a move to remove stolen defective models that have been offered for sale il...[ Price : $8.95]
Based on recent disappointing study data, Neurocrine Biosciences says it is stopping the development of two drugs being evaluated ...[ Price : $8.95]
Federal Register notice: FDA announces an 11/29 advisory committee meeting to discuss multi-cancer detection IVDs.